Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine
暂无分享,去创建一个
[1] Shixia Wang,et al. EV71: an emerging infectious disease vaccine target in the Far East? , 2010, Vaccine.
[2] P. McMinn. The emergence of enterovirus 71 as a major cause of acute neurological disease in young children of the Asia-Pacific region , 2006, Journal of Pediatric Infectious Diseases.
[3] Hongling Zhao,et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys , 2011, Laboratory Investigation.
[4] E. H. Lennette,et al. An apparently new enterovirus isolated from patients with disease of the central nervous system. , 1974, The Journal of infectious diseases.
[5] Wenfei Zhu,et al. Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection , 2012, BMC Infectious Diseases.
[6] Ching-Chuan Liu,et al. Enterovirus 71: epidemiology, pathogenesis and management , 2009, Expert review of anti-infective therapy.
[7] H. Lei,et al. Cytokine Immunopathogenesis of Enterovirus 71 Brain Stem Encephalitis , 2012, Clinical & developmental immunology.
[8] B. Böttiger,et al. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008 , 2011, Scandinavian journal of infectious diseases.
[9] F. Zhu,et al. Immunogenicity, Safety, and Lot Consistency of a Novel Inactivated Enterovirus 71 Vaccine in Chinese Children Aged 6 to 59 Months , 2013, Clinical and Vaccine Immunology.
[10] Sheng-Wen Huang,et al. Reemergence of Enterovirus 71 in 2008 in Taiwan: Dynamics of Genetic and Antigenic Evolution from 1998 to 2008 , 2009, Journal of Clinical Microbiology.
[11] P. Phuektes,et al. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. , 2011, Vaccine.
[12] Jen-Ren Wang,et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. , 2003, The Journal of infectious diseases.
[13] C. Partidos,et al. Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice , 2013, PloS one.
[14] H. Pan,et al. Patterns of polymorphism and divergence in the VP1 gene of enterovirus 71 circulating in the Asia-Pacific region between 1994 and 2013. , 2013, Journal of virological methods.
[15] I. Sam,et al. Enterovirus 71 Outbreak, Brunei , 2009, Emerging infectious diseases.
[16] Pei Liu,et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial , 2013, The Lancet.
[17] T. Yeh,et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] T. Tsang,et al. Estimation of the Basic Reproduction Number of Enterovirus 71 and Coxsackievirus A16 in Hand, Foot, and Mouth Disease Outbreaks , 2011, The Pediatric infectious disease journal.
[19] Jen-Ren Wang,et al. Therapeutic efficacy of milrinone in the management of enterovirus 71‐induced pulmonary edema , 2005, Pediatric pulmonology.
[20] Y. Chow,et al. Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection , 2013, Journal of Virology.
[21] Yongqiang Deng,et al. Antibody dependent enhancement infection of Enterovirus 71 in vitro and in vivo , 2011, Virology Journal.
[22] N. Xia,et al. The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children , 2013, PloS one.
[23] T. Wakita,et al. Tyrosine Sulfation of the Amino Terminus of PSGL-1 Is Critical for Enterovirus 71 Infection , 2010, PLoS pathogens.
[24] H. Lei,et al. A murine oral enterovirus 71 infection model with central nervous system involvement. , 2004, The Journal of general virology.
[25] Szu-Wei Huang,et al. Molecular Epidemiology of Enterovirus 71 Infection in the Central Region of Taiwan from 2002 to 2012 , 2013, PloS one.
[26] Shainn-Wei Wang,et al. Enterovirus 71 Infection of Human Dendritic Cells , 2009, Experimental biology and medicine.
[27] M. Ho,et al. Annexin II Binds to Capsid Protein VP1 of Enterovirus 71 and Enhances Viral Infectivity , 2011, Journal of Virology.
[28] Feng Ruan,et al. Risk Factors for Hand, Foot, and Mouth Disease and Herpangina and the Preventive Effect of Hand-washing , 2011, Pediatrics.
[29] Mei-Chih Huang,et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[30] Y. Kawaoka,et al. Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications , 2003, Reviews in medical virology.
[31] Jen-Ren Wang,et al. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells , 2012, BMC Microbiology.
[32] L. Wahl,et al. Perspectives on the basic reproductive ratio , 2005, Journal of The Royal Society Interface.
[33] Jen-Ren Wang,et al. Genetic and Antigenic Characterization of Enterovirus 71 in Ho Chi Minh City, Vietnam, 2011 , 2013, PloS one.
[34] Jia Jun Lee,et al. A Non-Mouse-Adapted Enterovirus 71 (EV71) Strain Exhibits Neurotropism, Causing Neurological Manifestations in a Novel Mouse Model of EV71 Infection , 2011, Journal of Virology.
[35] SB Halstead,et al. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.
[36] Ho‐Sheng Wu,et al. Antigenic and Genetic Diversity of Human Enterovirus 71 from 2009 to 2012, Taiwan , 2013, PloS one.
[37] Shun-Hua Chen,et al. Lymphocyte and Antibody Responses Reduce Enterovirus 71 Lethality in Mice by Decreasing Tissue Viral Loads , 2009, Journal of Virology.
[38] Xing Wu,et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial , 2013, The Lancet.
[39] W. Ryu,et al. Enterovirus 71 Infection with Central Nervous System Involvement, South Korea , 2010, Emerging infectious diseases.
[40] D. Dimitrov,et al. Virus entry: molecular mechanisms and biomedical applications , 2004, Nature Reviews Microbiology.
[41] S. Koike,et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.
[42] P. Chong,et al. Protective Efficacy of VP1-Specific Neutralizing Antibody Associated with a Reduction of Viral Load and Pro-Inflammatory Cytokines in Human SCARB2-Transgenic Mice , 2013, PloS one.
[43] K. Tsao,et al. An Investigation of Epidemic Enterovirus 71 Infection in Taiwan, 2008: Clinical, Virologic, and Serologic Features , 2010, The Pediatric infectious disease journal.
[44] K. Fujii,et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis , 2013, Proceedings of the National Academy of Sciences.
[45] H. Lei,et al. Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement , 2010, Clinical and Vaccine Immunology.
[46] K. Wong,et al. Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease , 2009, Journal of Virology.
[47] I. Sam,et al. Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor , 2012, Journal of Virology.
[48] P. Chong,et al. Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71 , 2013, PloS one.
[49] C. Qin,et al. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[50] Hyunwook Lee,et al. Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction , 2013, PLoS pathogens.
[51] Yhu-Chering Huang,et al. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] Rong-cheng Li,et al. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. , 2012, Vaccine.
[53] A. Nomoto,et al. Receptor-Dependent and -Independent Axonal Retrograde Transport of Poliovirus in Motor Neurons , 2009, Journal of Virology.
[54] Yufen Xu,et al. Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71 , 2013, BMC Infectious Diseases.
[55] Wenbo Xu,et al. The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008 , 2011, PloS one.
[56] M. Phoon,et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[57] Mei-Chih Huang,et al. Long-term Cognitive and Motor Deficits After Enterovirus 71 Brainstem Encephalitis in Children , 2006, Pediatrics.
[58] Tom Solomon,et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. , 2010, The Lancet. Infectious diseases.
[59] Huaxi Xu,et al. Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71 , 2012, Journal of medical virology.
[60] Wenbo Xu,et al. Emergence and Transmission Pathways of Rapidly Evolving Evolutionary Branch C4a Strains of Human Enterovirus 71 in the Central Plain of China , 2011, PloS one.
[61] M. Pallansch,et al. Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998 , 1999, Journal of Virology.
[62] N. Zhao,et al. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease , 2012, Scandinavian journal of infectious diseases.
[63] J. Deshpande,et al. Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype , 2003 .
[64] Zhenglun Liang,et al. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial. , 2014, The Journal of infectious diseases.
[65] P. Simmonds,et al. The Association of Recombination Events in the Founding and Emergence of Subgenogroup Evolutionary Lineages of Human Enterovirus 71 , 2011, Journal of Virology.
[66] H. Lei,et al. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice , 2011, Respiratory research.
[67] S. Trasti,et al. Sustained High Levels of Interleukin-6 Contribute to the Pathogenesis of Enterovirus 71 in a Neonate Mouse Model , 2011, Journal of Virology.
[68] B. Lina,et al. Epidemiology of human enterovirus 71 infections in France, 2000-2009. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[69] Ya-Fang Wang,et al. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine. , 2011, Vaccine.
[70] Kow-Tong Chen,et al. The Association between Enterovirus 71 Infections and Meteorological Parameters in Taiwan , 2012, PloS one.
[71] Kow-Tong Chen,et al. Epidemiologic Features of Hand-Foot-Mouth Disease and Herpangina Caused by Enterovirus 71 in Taiwan, 1998–2005 , 2007, Pediatrics.
[72] Jen-Ren Wang,et al. Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers , 2013, PloS one.
[73] K. Fujii,et al. Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71 , 2013, Journal of Virology.
[74] T. Solomon,et al. Clinical features, diagnosis, and management of enterovirus 71 , 2010, The Lancet Neurology.
[75] K. Chu,et al. Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants , 2012, The Pediatric infectious disease journal.
[76] Min-Shi Lee,et al. Development of enterovirus 71 vaccines , 2010, Expert review of vaccines.
[77] Jen-Ren Wang,et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. , 2008, The Journal of infectious diseases.
[78] M. Koopmans,et al. Epidemiology of Enterovirus 71 in The Netherlands, 1963 to 2008 , 2009, Journal of Clinical Microbiology.
[79] S. Dowell,et al. What we are watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection Operations Center , 2013, Emerging health threats journal.
[80] I. Su,et al. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. , 2013, The Journal of general virology.
[81] M. Shimojima,et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.
[82] S. Self,et al. Implications of Age-Dependent Immune Responses to Enterovirus 71 Infection for Disease Pathogenesis and Vaccine Design. , 2013, Journal of the Pediatric Infectious Diseases Society.
[83] Da-yong Dong,et al. Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection , 2013, PloS one.
[84] H. Lei,et al. Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity , 2011, European Journal of Clinical Microbiology & Infectious Diseases.
[85] K. Fujii,et al. Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71 , 2012, Journal of Virology.
[86] T. Solomon,et al. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. , 2012, The Journal of infectious diseases.